CP Kelco:企業の戦略・SWOT・財務情報

◆英語タイトル:CP Kelco - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1585
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

CP Kelco – Strategy, SWOT and Corporate Finance Report
Summary

CP Kelco – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CP Kelco (Kelco), a subsidiary of J.M. Huber Corporation, is a manufacturer and marketer of specialty hydrocolloids. The company primarily offers carageenan, cellulose gums, diutan gums, gellan gums, whey protein concentrates, pectin, refined locust bean gums, welan gums and xanthan gums. CP Kelco markets its products under the brands of Genu, Genu pHresh, Genugel, Genuvisco, Cekol, Slendid, Keltrol, Kelcogel and Simplesse, among others. The company’s products find application in food, beverage, personal care, oral care, pharmaceutical, household products, industrial, papermaking and oilfield drilling markets. It operates in the US, Argentina, Belgium, Brazil, China, the UAE, Denmark, Finland, France, Germany, India, Japan, Korea, Mexico, Poland, Russia, Singapore and the UK. CP Kelco is headquartered in Atlanta, Georgia, the US.

Scope

- Detailed information on CP Kelco required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CP Kelco in the form of a SWOT analysis
- An in-depth view of the business model of CP Kelco including a breakdown and examination of key business segments
- Intelligence on CP Kelco’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CP Kelco, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of CP Kelco and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess CP Kelco as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on CP Kelco’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
CP Kelco: Company Overview 7
CP Kelco: Overview and Key Facts 7
CP Kelco: Overview 7
CP Kelco: Key Facts 7
CP Kelco: Key Employees 8
CP Kelco: Key Employee Biographies 9
CP Kelco: Locations and Subsidiaries 10
CP Kelco: Key Competitors 12
CP Kelco: Corporate Financial Deals Activity 13
CP Kelco: Financial Deals Overview 13
CP Kelco: Top Deals 2014 – 2018YTD* 15
CP Kelco: Divestments 16
CP Kelco: Recent Developments 17
CP Kelco: News and Events Summary 17
CP Kelco: Business Expansion 18
CP Kelco: Corporate Governance 18
CP Kelco: Financial Deals 18
CP Kelco: Regulatory and Legal Events 19
CP Kelco: Strategy and Operations 19
Appendix 20
Contact Us 20
Methodology 20
About MarketLine 21

List of Tables
Table 1: CP Kelco: Key Facts
Table 2: CP Kelco: Key Employees
Table 3: CP Kelco: Locations and Subsidiaries
Table 4: CP Kelco: Key Competitors
Table 5: CP Kelco: Deal Activity by Deal Type - Volume (TTM*)
Table 6: CP Kelco: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: CP Kelco: Top Deals 2014 - 2018YTD*
Table 8: CP Kelco: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: CP Kelco: News and Events Summary
Table 10: CP Kelco: Business Expansion
Table 11: CP Kelco: Corporate Governance
Table 12: CP Kelco: Financial Deals
Table 13: CP Kelco: Regulatory and Legal Events
Table 14: CP Kelco: Strategy and Operations

List of Figures
Figure 1: CP Kelco: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: CP Kelco: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: CP Kelco: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[CP Kelco:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) operates as a clinical-stage biopharmaceutical company. It carries out research, develop and commercialize gene editing technology. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target a …
  • ServiceNow Inc (NOW):企業の財務・戦略的SWOT分析
    ServiceNow Inc (NOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Efora Energy Ltd (EEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Efora Energy Ltd (Efora Energy), formerly SacOil Holdings Ltd, a subsidiary of Public Investment Corp Ltd, is an independent oil and gas exploration and production company that acquires, explores, develops and produces hydrocarbon assets in Africa. The company holds a diverse portfolio of as …
  • Sanyo Chemical Industries Ltd (4471):企業の財務・戦略的SWOT分析
    Sanyo Chemical Industries Ltd (4471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • Enel SpA (ENEL):企業の財務・戦略的SWOT分析
    Enel SpA (ENEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NSK Ltd (6471):企業の財務・戦略的SWOT分析
    NSK Ltd (6471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Ceragon Networks Ltd (CRNT):企業の財務・戦略的SWOT分析
    Ceragon Networks Ltd (CRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Horizon Discovery Group Plc (HZD):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務情報
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Real Goods Solar Inc (RGSE):電力:M&Aディール及び事業提携情報
    Summary Real Goods Solar Inc (Real Goods Solar), doing business as RGS Energy, a subsidiary of Gaia Inc is a renewable energy company that offers solar energy products and solutions. The company's services include solar PV system designing, installation, consultation, maintenance, rebate acquisition …
  • Cantel Medical Corp (CMD):医療機器:M&Aディール及び事業提携情報
    Summary Cantel Medical Corp (Cantel) is a provider of infection prevention and control products and services for the healthcare market. Its product portfolio includes endoscopy procedure disposables, medical device reprocessing systems, detergents, disinfectants, water purification systems, filtrati …
  • Genpact Limited:企業のM&A・事業提携・投資動向
    Genpact Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genpact Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Marsh & McLennan Companies Inc:企業の戦略・SWOT・財務分析
    Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Merck KGaA (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …
  • Sembcorp Industries Ltd (U96)-エネルギー分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary NicOx SA (NicOx) is an ophthalmology company that develops solutions to help maintain vision and improve ocular health. The company’s products include Vyzulta, a latanoprostene bunod ophthalmic solution; and Zerviate, a cetirizine ophthalmic solution. It offers products in the therapeutic ar …
  • Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析
    Summary Tibet Rhodiola Pharmaceutical Holding Co Ltd (TRPHC) is a pharmaceutical company that manufactures and markets Chinese medicine. The company’s products include children shuangqing particles, little dragon capsule, nuodikang capsule, shuxioang capsules, snowy jin luohan analgesic balm, pu yu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆